| Oct 3 |
Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors
|
| Oct 1 |
Foghorn Therapeutics to Participate in the BMO Oncology Summit
|
| Sep 16 |
Strength Seen in Foghorn Therapeutics (FHTX): Can Its 9.5% Jump Turn into More Strength?
|
| Sep 11 |
Insider Sale: Chief Scientific Officer Steven Bellon Sells 20,000 Shares of Foghorn ...
|
| Sep 3 |
Foghorn Therapeutics Strengthens Leadership Team with Appointment of Anna Rivkin, Ph.D. as Chief Business Officer
|
| Sep 2 |
Wall Street Analysts Think Foghorn Therapeutics (FHTX) Could Surge 81.16%: Read This Before Placing a Bet
|
| Aug 28 |
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences in September
|
| Aug 19 |
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
| Aug 19 |
Zacks Industry Outlook Highlights Corcept, Amneal, Bioventus, Foghorn and Akebia
|
| Aug 16 |
Wall Street Analysts Believe Foghorn Therapeutics (FHTX) Could Rally 121.77%: Here's is How to Trade
|
